ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...
Original story from Technion-Israel Institute of Technology (Haifa, Israel). An implantable tissue flap containing muscle and ...
Researchers are improving the odds for patients with the development of an implantable soft electronic vascular monitoring system. Their smart stent and printed soft sensors, is capable of wireless ...
An international research team led by the Levenberg Laboratory in the Faculty of Biomedical Engineering at the ...
Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow ...
Historically, much of the research conducted in our 'Heart Lab' has been at the interface of medicine and engineering, dedicated to the discovery and development of innovative methodologies (molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results